Position in LCTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,847,694
-$555,011 QoQ
Shares Held
1,169,427
-18.7% QoQ
Ownership
0.469%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. LCTX ranks #224 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in LCTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,847,694 | 1,169,427 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,402,705 | 1,438,746 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $244,501 | 144,676 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $163,971 | 180,189 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $157,546 | 350,103 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $192,532 | 385,066 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $222,243 | 244,224 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $164,584 | 164,584 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $39,299 | 26,554 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $40,817 | 37,447 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $35,269 | 29,890 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $37,393 | 26,520 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $419,653 | 279,769 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $16,472 | 14,079 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $17,484 | 15,473 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $126,666 | 80,169 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $196,244 | 127,432 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $241,714 | 98,659 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $244,618 | 97,071 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $38,115 | 13,374 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $466,799 | 198,638 | Shares | Defined | 2021-05-17 | |
| 2020-06-30 | $105,181 | 120,899 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $54,539 | 65,710 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||